‘Imperfect Compromise’ On EU Pharma Legislation Still Offers Progress
Medicines For Europe Says Latest Parliament Position ‘Accelerates Much Needed Reform’
Reacting to the latest position on the EU pharma legislation overhaul adopted by a European Parliament committee – including changes to previous proposals on regulatory data protection – Medicines for Europe said that the “imperfect” compromise nevertheless offers improvements.
